Rigel Pharmaceuticals Statistics
Total Valuation
RIGL has a market cap or net worth of $255.13 million. The enterprise value is $306.34 million.
Important Dates
The next confirmed earnings date is Thursday, November 7, 2024, after market close.
Earnings Date | Nov 7, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
RIGL has 17.59 million shares outstanding. The number of shares has increased by 0.93% in one year.
Current Share Class | 17.59M |
Shares Outstanding | 17.59M |
Shares Change (YoY) | +0.93% |
Shares Change (QoQ) | +0.16% |
Owned by Insiders (%) | 1.15% |
Owned by Institutions (%) | 47.08% |
Float | 14.73M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 32.73 |
PS Ratio | 1.95 |
Forward PS | 1.41 |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 2.35 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.62
Current Ratio | 1.62 |
Quick Ratio | 1.33 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -1.18 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -4.64% |
Return on Capital (ROIC) | -7.73% |
Revenue Per Employee | $885,721 |
Profits Per Employee | -$96,816 |
Employee Count | 147 |
Asset Turnover | 1.06 |
Inventory Turnover | 2.86 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +64.57% in the last 52 weeks. The beta is 0.95, so RIGL's price volatility has been similar to the market average.
Beta (5Y) | 0.95 |
52-Week Price Change | +64.57% |
50-Day Moving Average | 14.52 |
200-Day Moving Average | 12.16 |
Relative Strength Index (RSI) | 49.12 |
Average Volume (20 Days) | 91,827 |
Short Selling Information
The latest short interest is 717,989, so 4.08% of the outstanding shares have been sold short.
Short Interest | 717,989 |
Short Previous Month | 463,528 |
Short % of Shares Out | 4.08% |
Short % of Float | 4.88% |
Short Ratio (days to cover) | 3.48 |
Income Statement
In the last 12 months, RIGL had revenue of $130.20 million and -$14.23 million in losses. Loss per share was -$0.81.
Revenue | 130.20M |
Gross Profit | 99.08M |
Operating Income | -9.12M |
Pretax Income | -14.23M |
Net Income | -14.23M |
EBITDA | -7.52M |
EBIT | -9.12M |
Loss Per Share | -$0.81 |
Full Income Statement Balance Sheet
The company has $49.10 million in cash and $100.31 million in debt, giving a net cash position of -$51.21 million or -$2.91 per share.
Cash & Cash Equivalents | 49.10M |
Total Debt | 100.31M |
Net Cash | -51.21M |
Net Cash Per Share | -$2.91 |
Equity (Book Value) | -29.91M |
Book Value Per Share | -1.70 |
Working Capital | 36.07M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -12.31M |
Capital Expenditures | n/a |
Free Cash Flow | -12.31M |
FCF Per Share | -$0.70 |
Full Cash Flow Statement Margins
Gross margin is 76.10%, with operating and profit margins of -7.00% and -10.93%.
Gross Margin | 76.10% |
Operating Margin | -7.00% |
Pretax Margin | -10.93% |
Profit Margin | -10.93% |
EBITDA Margin | -5.78% |
EBIT Margin | -7.00% |
FCF Margin | -9.62% |
Dividends & Yields
RIGL does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.93% |
Shareholder Yield | -0.93% |
Earnings Yield | -5.58% |
FCF Yield | -4.83% |
Analyst Forecast
The average price target for RIGL is $31.13, which is 114.69% higher than the current price. The consensus rating is "Buy".
Price Target | $31.13 |
Price Target Difference | 114.69% |
Analyst Consensus | Buy |
Analyst Count | 4 |
Revenue Growth Forecast (5Y) | 20.18% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
The last stock split was on June 27, 2024. It was a reverse split with a ratio of 0.1:1.
Last Split Date | Jun 27, 2024 |
Split Type | Reverse |
Split Ratio | 0.1:1 |
Scores
RIGL has an Altman Z-Score of -13.57 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -13.57 |
Piotroski F-Score | 4 |